Free Trial

Chemed Co. (NYSE:CHE) Shares Sold by Candriam S.C.A.

Chemed logo with Medical background
Remove Ads

Candriam S.C.A. lessened its stake in Chemed Co. (NYSE:CHE - Free Report) by 8.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,683 shares of the company's stock after selling 1,328 shares during the period. Candriam S.C.A. owned about 0.10% of Chemed worth $7,779,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also made changes to their positions in the company. UMB Bank n.a. boosted its holdings in Chemed by 300.0% during the fourth quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares in the last quarter. Trust Co. of Vermont acquired a new position in shares of Chemed in the fourth quarter worth about $34,000. SRS Capital Advisors Inc. boosted its stake in shares of Chemed by 39.2% during the 4th quarter. SRS Capital Advisors Inc. now owns 135 shares of the company's stock worth $72,000 after acquiring an additional 38 shares in the last quarter. Allworth Financial LP grew its position in shares of Chemed by 2,057.1% during the 4th quarter. Allworth Financial LP now owns 151 shares of the company's stock valued at $83,000 after acquiring an additional 144 shares during the period. Finally, Farther Finance Advisors LLC grew its position in shares of Chemed by 2,314.3% during the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock valued at $203,000 after acquiring an additional 324 shares during the period. Institutional investors and hedge funds own 95.85% of the company's stock.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Chemed from a "hold" rating to a "buy" rating in a research report on Friday.

Remove Ads

View Our Latest Report on Chemed

Insider Buying and Selling

In other news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $593.67, for a total transaction of $1,187,340.00. Following the sale, the chief executive officer now directly owns 102,679 shares in the company, valued at approximately $60,957,441.93. This trade represents a 1.91 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by insiders.

Chemed Price Performance

NYSE CHE traded up $1.36 on Tuesday, hitting $598.12. The company had a trading volume of 124,403 shares, compared to its average volume of 101,867. The company's fifty day moving average price is $555.23 and its 200-day moving average price is $564.08. The company has a market capitalization of $8.75 billion, a PE ratio of 30.22, a PEG ratio of 2.15 and a beta of 0.43. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $654.62.

Chemed Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. The ex-dividend date is Monday, February 24th. Chemed's dividend payout ratio is presently 10.05%.

About Chemed

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Should You Invest $1,000 in Chemed Right Now?

Before you consider Chemed, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.

While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Time to Buy SoFi? Fintech’s Next Big Move
3 Chip Stocks Primed for a Comeback—Have They Found the Bottom?
Why Palantir’s Future Just Got a Massive Boost

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads